Website update in progress

Following the transformation of Polpharma Biologics (learn more), this site will focus on biosimilars development in Switzerland. In Poland, we operate now as Rezon Bio – a contract developer and manufacturer of biologics (CDMO). More at www.rezonbio.com.

Due to the demerger of Polpharma Biologics into two independent companies (detailed information can be found in the “Knowledge center” section), the website polpharmabiologics.com is currently being updated. For details on the CDMO business, please visit the Rezon Bio website

Safety

The safety of employees and contractors is the most important value. In order to take care of it together, please familiarize yourself with the content of the EHS Program for external companies providing services on the premises of Polpharma Biologics. The Program contains the most important principles applicable on the premises of our company.

All work of external companies, as well as the movement of people, must be planned and carried out with great caution so as not to affect employees directly or indirectly, products and the functioning of our factory. At every stage of creating biological drugs, it is necessary to maintain the highest standards and processes of operation, because even a small deviation can ruin the many months of their creation process, and thus significantly delay the delivery of drugs to hundreds of thousands of patients around the world.

Files to download: